193 related articles for article (PubMed ID: 24922178)
1. Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents.
Boros E; Karimi S; Kenton N; Helm L; Caravan P
Inorg Chem; 2014 Jul; 53(13):6985-94. PubMed ID: 24922178
[TBL] [Abstract][Full Text] [Related]
2. Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.
Polasek M; Caravan P
Inorg Chem; 2013 Apr; 52(7):4084-96. PubMed ID: 23517079
[TBL] [Abstract][Full Text] [Related]
3. Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.
Boros E; Caravan P
Inorg Chem; 2015 Mar; 54(5):2403-10. PubMed ID: 25693053
[TBL] [Abstract][Full Text] [Related]
4. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
5. Relaxometric and solution NMR structural studies on ditopic lanthanide(III) complexes of a phosphinate analogue of DOTA with a fast rate of water exchange.
Rudovský J; Botta M; Hermann P; Koridze A; Aime S
Dalton Trans; 2006 May; (19):2323-33. PubMed ID: 16688320
[TBL] [Abstract][Full Text] [Related]
6. Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.
Boros E; Polasek M; Zhang Z; Caravan P
J Am Chem Soc; 2012 Dec; 134(48):19858-68. PubMed ID: 23157602
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging.
Laurent S; Vander Elst L; Galaup C; Leygue N; Boutry S; Picard C; Muller RN
Contrast Media Mol Imaging; 2014; 9(4):300-12. PubMed ID: 24706614
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies.
Lebdusková P; Hermann P; Helm L; Tóth E; Kotek J; Binnemans K; Rudovský J; Lukes I; Merbach AE
Dalton Trans; 2007 Jan; (4):493-501. PubMed ID: 17213936
[TBL] [Abstract][Full Text] [Related]
9. Lanthanide Complexes of DO3A-(Dibenzylamino)methylphosphinate: Effect of Protonation of the Dibenzylamino Group on the Water-Exchange Rate and the Binding of Human Serum Albumin.
Urbanovský P; Kotek J; Carniato F; Botta M; Hermann P
Inorg Chem; 2019 Apr; 58(8):5196-5210. PubMed ID: 30942072
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin targeted, pH-dependent magnetic resonance relaxation agents.
Moriggi L; Yaseen MA; Helm L; Caravan P
Chemistry; 2012 Mar; 18(12):3675-86. PubMed ID: 22328098
[TBL] [Abstract][Full Text] [Related]
11. Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent.
Caravan P; Parigi G; Chasse JM; Cloutier NJ; Ellison JJ; Lauffer RB; Luchinat C; McDermid SA; Spiller M; McMurry TJ
Inorg Chem; 2007 Aug; 46(16):6632-9. PubMed ID: 17625839
[TBL] [Abstract][Full Text] [Related]
12. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
13. High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity.
Jacques V; Dumas S; Sun WC; Troughton JS; Greenfield MT; Caravan P
Invest Radiol; 2010 Oct; 45(10):613-24. PubMed ID: 20808234
[TBL] [Abstract][Full Text] [Related]
14. pH-sensitive modulation of the second hydration sphere in lanthanide(III) tetraamide-DOTA complexes: a novel approach to smart MR contrast media.
Woods M; Zhang S; Ebron VH; Sherry AD
Chemistry; 2003 Oct; 9(19):4634-40. PubMed ID: 14566868
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields.
Kotková Z; Helm L; Kotek J; Hermann P; Lukeš I
Dalton Trans; 2012 Nov; 41(43):13509-19. PubMed ID: 23018269
[TBL] [Abstract][Full Text] [Related]
16. Ternary Gd(III)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI.
Aime S; Gianolio E; Terreno E; Giovenzana GB; Pagliarin R; Sisti M; Palmisano G; Botta M; Lowe MP; Parker D
J Biol Inorg Chem; 2000 Aug; 5(4):488-97. PubMed ID: 10968620
[TBL] [Abstract][Full Text] [Related]
17. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin.
Ou MH; Tu CH; Tsai SC; Lee WT; Liu GC; Wang YM
Inorg Chem; 2006 Jan; 45(1):244-54. PubMed ID: 16390062
[TBL] [Abstract][Full Text] [Related]
19. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derived, redox-sensitive contrast agents for magnetic resonance imaging.
Raghunand N; Guntle GP; Gokhale V; Nichol GS; Mash EA; Jagadish B
J Med Chem; 2010 Sep; 53(18):6747-57. PubMed ID: 20722424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
